September 2019

Higher-dose statins raise risk for osteoporosis ()
CVS halts all sales of Zantac, store-brand ranitidine ()
3-year COAPT results bolster MitraClip’s success ()
Frequent, persistent hot flashes predict later CVD events ()
FDA greenlights early feasibility study for less-invasive TMVR system ()
Bootleg cannabis pens found to contain vitamin E, pesticides ()
Shorter-duration DAPT looks favorable for patients at a high risk of bleeding after PCI ()
Robocath completes 1st in-human robotic angioplasties ()
ABSORB III: 5-year results offer renewed hope for bioresorbable stents ()
1 in 4 MI survivors confused about the role of aspirin in secondary prevention ()
Idaho electrophysiologist 1st woman to complete 1,000 robotic catheter ablations ()
PCI mortality rates poor indicators of hospital quality ()
Communication training improves end-of-life discussions between HF patients, physicians ()
New Jersey cardiologist goes to trial for sexual misconduct ()
Europe’s 1st digital health CV conference kicks off in October ()
Machine learning cuts cardiac MRI analysis from minutes to seconds ()
Exposure to secondhand smoke in childhood increases lifetime risk of AFib ()
FDA expands losartan recall—again ()
Therapeutic shoe improves stroke survivors’ gait, symmetry ()
Treating hypertension could slow cognitive decline ()
Cardiac amyloidosis increasingly common in US ()
UNC Children’s cleared to resume complex heart surgeries ()
At-home BP tests more accurate for black patients ()
High-dose radiation improves survival in tachycardia patients ()
Failed TAVR more common in women, those with PAD ()
ACC takes steps toward equal pay, opportunity with new guidance ()
Zantac pulled from global markets amid investigation ()
‘Alarming’ number of heart infections can be traced back to opioid epidemic ()
Surgical bailout during TAVR linked to poor outcomes ()
More female trainees, but still not enough women in cardiology ()
NLA endorses icosapent ethyl for use in high-risk patients ()
Study finds aspirin beneficial for some without established CVD ()
CIED infection rates on the rise ()
A Fresh Look at Case Mix Index: A Multidisciplinary Approach to Maximize Reimbursement ()
Dapagliflozin fast-tracked again—this time to treat heart failure ()
Focused ultrasound helps screen for heart disease in cats ()
ASNC releases multisocietal amyloidosis imaging guidelines ()
FDA warns of probable carcinogens in Zantac, other heartburn drugs ()
Apple launches a new heart study ()
Study adds to pool of evidence that paclitaxel-coated devices are safe ()
Men with erectile dysfunction prone to heart disease, stroke ()
Quicker diagnosis protocol for suspected ACS fails to improve outcomes ()
Napping twice a week lowers risk of CVD ()
Neural network IDs congestive heart failure with 100% accuracy ()
Fluoroquinolone use predicts aortic, mitral regurgitation ()
On Revolution ()
Tracks & Training at TCT.19: The 2019 Transcatheter Cardiovascular Therapeutics scientific symposium will convene Sept. 25-29 in San Francisco. ()
Chicago company 3D-bioprints mini human heart ()
Almost 2/3 of medical students have higher-than-normal blood pressure ()
Pocket-sized: Pointers for Using (& Not Using) Handheld Point-of-Care Echocardiography ()
Algorithmic Potential: Leveraging Deep Learning to Improve Arrhythmia Identification & Classification ()
‘We’re moving in the wrong direction’: Why younger people are having more heart attacks ()
Tackling the Undertreatment of Aortic Stenosis in the U.S. ()
Transcarotid Access: The Future of Non-femoral TAVR? ()
As Surgery Gives Way to Transcatheter Procedures, Is the Cardiology Cash Cow in Jeopardy? ()
FDA Expands Indication for TAVR to Low-risk Patients ()
FDA slams Juul for marketing e-cigarettes as ‘totally safe’ ()
Who Shouldn’t Get TAVR? Lower-risk TAVR Raises New Challenges Around Assessing Patient Eligibility ()
Hub & Spoke: Improving Cardiogenic Shock Outcomes at WellStar ()
Native Hawaiians successfully lower BP with hula program ()
18 years later: What 9/11 meant for firefighters’ heart health ()
Gut bacteria helps researchers ID new types of hypertension ()
30% of ICD patients drive illegally after procedure ()
Vitamin E could be the culprit behind vaping-related lung disease ()
Motivational texting helps those with diabetes, CHD control glucose ()
Orchestra BioMed earns CE mark for BackBeat cardiac neuromodulation therapy ()
Educational status predicts death, CV events ()
Malaria tied to 30% increased risk of HF ()
Photoplethysmography promising as AFib screening tool ()
French startup Robocath raises $5.5M for CV robotics platform ()
Men who live alone struggle with taking warfarin ()
Cardiovascular RCTs are getting more practical—but slowly ()
Biodegradable polymer-coated DES safe, effective at 3 years ()
Cancer replaces CVD as no. 1 killer in high-income countries ()
Yearly flu shot decreases risk of death for hypertensive patients ()
Complete revascularization more beneficial than culprit-only PCI after STEMI ()